NutriBand Inc.
corporate_fare Company Profile
NutriBand Inc. (NASDAQ:NTRB) is a publicly traded company in the Life Sciences sector. Wiseek monitors NTRB SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- NutriBand Secures $5M Non-Convertible Credit Line at 7% for AVERSA FDA Approval
- NutriBand Secures $5M Non-Convertible Credit Line Extension for Fentanyl Patch Commercialization
- NutriBand Q3 Revenue Plunges 35% to $433K as Key Customer Shifts Operations
- Q1 Revenue Declines 35% to $433K, Net Loss Narrows, Going Concern Alleviated with $5M Credit Line Extension
- Nutriband Subsidiary to Showcase New AI Wellness Products to Walmart, Amazon Buyers at ECRM Conference
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for NTRB, detected from its recent SEC filings · based on capital-structure filings through 2026-02-12.
Significant Net Loss for Common Stockholders · Substantial Preferred Stock Dividend Issued
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →